• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Change Healthcare Inc. (Amendment)

    2/14/22 11:59:59 AM ET
    $CHNG
    Managed Health Care
    Health Care
    Get the next $CHNG alert in real time by email
    SC 13G/A 1 d105873dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

    Change Healthcare Inc.

    (Name of Issuer)

    Common Stock, par value $0.001 per share

    (Title of Class of Securities)

    15912K100

    (CUSIP Number)

    December 31, 2021

    (Date of Event which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    Except as otherwise provided herein, beneficial ownership information contained herein is given as of the date listed above.

     

     

     


      1    

      Names of Reporting Persons.

     

      Abrams Capital Partners II, L.P.

      Abrams Capital, LLC

      Abrams Capital Management, LLC

      Abrams Capital Management, L.P.

      David Abrams

      2  

      Check the Appropriate Box if a Member of a Group (See Instructions)

     

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization.

     

      Abrams Capital Partners II, L.P. – Delaware

      Abrams Capital, LLC - Delaware

      Abrams Capital Management, LLC - Delaware

      Abrams Capital Management, L.P. - Delaware

      David Abrams - United States

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5    

      Sole Voting Power

     

      Abrams Capital Partners II, L.P. - 0 shares

      Abrams Capital, LLC - 0 shares

      Abrams Capital Management, LLC - 0 shares

      Abrams Capital Management, L.P. - 0 shares

      David Abrams - 0 shares

       6  

      Shared Voting Power

     

      Abrams Capital Partners II, L.P. – 14,620,281 shares

      Abrams Capital, LLC – 16,978,220 shares

      Abrams Capital Management, LLC - 16,978,220 shares

      Abrams Capital Management, L.P. - 16,978,220 shares

      David Abrams - 16,978,220 shares

       7  

      Sole Dispositive Power

     

      Abrams Capital Partners II, L.P. - 0 shares

      Abrams Capital, LLC - 0 shares

      Abrams Capital Management, LLC - 0 shares

      Abrams Capital Management, L.P. - 0 shares

      David Abrams - 0 shares

       8  

      Shared Dispositive Power

     

      Abrams Capital Partners II, L.P. – 14,620,281 shares

      Abrams Capital, LLC – 16,978,220 shares

      Abrams Capital Management, LLC - 16,978,220 shares

      Abrams Capital Management, L.P. - 16,978,220 shares

      David Abrams - 16,978,220 shares

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      Abrams Capital Partners II, L.P. – 14,620,281 shares

      Abrams Capital, LLC – 16,978,220 shares

      Abrams Capital Management, LLC - 16,978,220 shares

      Abrams Capital Management, L.P. - 16,978,220 shares

      David Abrams - 16,978,220 shares

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

      ☐

    11  

      Percent of Class Represented by Amount in Row (9)

     

      Abrams Capital Partners II, L.P. - 4.7%

      Abrams Capital, LLC - 5.4%

      Abrams Capital Management, LLC - 5.4%

      Abrams Capital Management, L.P. - 5.4%

      David Abrams - 5.4%

    12  

      Type of Reporting Person (See Instructions)

     

      Abrams Capital Partners II, L.P. - OO (Limited Partnership)

      Abrams Capital, LLC - OO (Limited Liability Company)

      Abrams Capital Management, LLC - OO (Limited Liability Company)

      Abrams Capital Management, L.P. - OO (Limited Partnership)

      David Abrams - IN


    SCHEDULE 13G

     

    Item 1

    (a) Name of Issuer

    Change Healthcare Inc.

    (b) Address of Issuer’s Principal Executive Offices

    424 Church Street, Suite 1400, Nashville, TN 37219

     

    Item 2

    (a) Name of Person Filing

    Abrams Capital Partners II, L.P.

    Abrams Capital, LLC

    Abrams Capital Management, LLC

    Abrams Capital Management, L.P.

    David Abrams

    (b) Address of Principal Business Office or, if none, Residence

    Abrams Capital Partners II, L.P.

    Abrams Capital, LLC

    Abrams Capital Management, LLC

    Abrams Capital Management, L.P.

    David Abrams

    c/o Abrams Capital Management, L.P.

    222 Berkeley Street, 21st Floor

    Boston, MA 02116

    (c) Citizenship

    Abrams Capital Partners II, L.P. – Delaware

    Abrams Capital, LLC - Delaware

    Abrams Capital Management, LLC - Delaware

    Abrams Capital Management, L.P. - Delaware

    David Abrams - United States

    (d) Title of Class of Securities

    Common Stock, par value $0.001 per share

    (e) CUSIP Number

    15912K100

     

    Item 3

    If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a)    ☐    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)    ☐    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)    ☐    Insurance Company as defined in Section 3(a)(19) of the Act;
    (d)    ☐    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
    (e)    ☐    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);


    (f)    ☐    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
    (g)    ☐    A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)    ☐    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)    ☐    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)    ☐    A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
    (k)    ☐    Group, in accordance with §240.13d-1(b)(1)(ii)(K).

    If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

     

    Item 4

    Ownership

    The percentages reported herein are calculated based upon the statement in the Issuer’s Report on Form 10-Q for the quarterly period ended December 31, 2021, as filed with the Securities and Exchange Commission on February 3, 2022, that there were 311,895,569 shares of Common Stock of the Issuer outstanding as of January 24, 2022.

     

    Item 4(a)

    Amount Beneficially Owned**

    Abrams Capital Partners II, L.P. – 14,620,281 shares

    Abrams Capital, LLC – 16,978,220 shares

    Abrams Capital Management, LLC - 16,978,220 shares

    Abrams Capital Management, L.P. - 16,978,220 shares

    David Abrams - 16,978,220 shares

     

    Item 4(b)

    Percent of Class

    Abrams Capital Partners II, L.P. - 4.7%

    Abrams Capital, LLC - 5.4%

    Abrams Capital Management, LLC - 5.4%

    Abrams Capital Management, L.P. - 5.4%

    David Abrams - 5.4%

     

    Item 4(c)

    Number of shares as to which each such person has voting and dispositive power:

    (i) sole power to vote or to direct the vote

    Abrams Capital Partners II, L.P. - 0 shares

    Abrams Capital, LLC - 0 shares

    Abrams Capital Management, LLC - 0 shares

    Abrams Capital Management, L.P. - 0 shares

    David Abrams - 0 shares

    (ii) shared power to vote or to direct the vote

    Abrams Capital Partners II, L.P. – 14,620,281 shares

    Abrams Capital, LLC – 16,978,220 shares

    Abrams Capital Management, LLC - 16,978,220 shares

    Abrams Capital Management, L.P. - 16,978,220 shares

    David Abrams - 16,978,220 shares

    (iii) sole power to dispose or to direct the disposition of

    Abrams Capital Partners II, L.P. - 0 shares

    Abrams Capital, LLC - 0 shares

    Abrams Capital Management, LLC - 0 shares

    Abrams Capital Management, L.P. - 0 shares

    David Abrams - 0 shares


    (iv) shared power to dispose or to direct the disposition of

    Abrams Capital Partners II, L.P. – 14,620,281 shares

    Abrams Capital, LLC – 16,978,220 shares

    Abrams Capital Management, LLC - 16,978,220 shares

    Abrams Capital Management, L.P. - 16,978,220 shares

    David Abrams - 16,978,220 shares

     

    ***

    Shares reported herein for Abrams Capital Partners II, L.P. (“ACP II”) represent shares beneficially owned by ACP II. Shares reported herein for Abrams Capital, LLC (“Abrams Capital”) represent shares beneficially owned by ACP II and other private investment funds for which Abrams Capital serves as general partner. Shares reported herein for Abrams Capital Management, L.P. (“Abrams CM LP”) and Abrams Capital Management, LLC (“Abrams CM LLC”) represent shares beneficially owned by ACP II and other private investment funds for which Abrams CM LP serves as investment manager. Abrams CM LLC is the general partner of Abrams CM LP. Shares reported herein for Mr. Abrams represent the above referenced shares reported for Abrams Capital, Abrams CM LLC and shares personally held by Mr. Abrams. Mr. Abrams is the managing member of Abrams Capital and Abrams CM LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein.

     

    Item 5

    Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐.

     

    Item 6

    Ownership of More than Five Percent on Behalf of Another Person

    Not applicable.

     

    Item 7

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

    Not applicable.

     

    Item 8

    Identification and Classification of Members of the Group

    Not applicable.

     

    Item 9

    Notice of Dissolution of Group

    Not applicable.

     

    Item 10

    Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

    Exhibits    Exhibit
    99.1    Joint Filing Agreement by and among the Reporting Persons, incorporated by reference to Exhibit 99.1 to the Schedule 13G filed by the Reporting Persons with the Securities and Exchange Commission on August 13, 2021.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: February 14, 2022

     

    ABRAMS CAPITAL PARTNERS II, L.P.
    By: Abrams Capital, LLC, its General Partner
    By:  

    /s/ David Abrams

    David Abrams, Managing Member
    ABRAMS CAPITAL, LLC
    By:  

    /s/ David Abrams

    David Abrams, Managing Member
    ABRAMS CAPITAL MANAGEMENT, LLC
    By:  

    /s/ David Abrams

    David Abrams, Managing Member
    ABRAMS CAPITAL MANAGEMENT, L.P.
    By: Abrams Capital Management, LLC, its General Partner
    By:  

    /s/ David Abrams

    David Abrams, Managing Member
    DAVID ABRAMS
    By:  

    /s/ David Abrams

    David Abrams, individually
    Get the next $CHNG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CHNG

    DatePrice TargetRatingAnalyst
    9/20/2022$26.00 → $27.75Overweight → Neutral
    Piper Sandler
    9/20/2022$27.75Buy → Neutral
    Citigroup
    9/7/2022$27.75Hold
    Truist
    4/1/2022$25.75Neutral
    Credit Suisse
    2/4/2022$25.75Neutral → Buy
    Citigroup
    More analyst ratings

    $CHNG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AM Best Comments on Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries Following Completion of Change Healthcare Inc. Acquisition

      AM Best has commented that the Credit Ratings (ratings) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH) and its insurance subsidiaries remain unchanged following its completed acquisition of Change Healthcare Inc. (Change Healthcare) (Nashville, TN) (NASDAQ:CHNG), a leading health care technology company. The outlooks of these Credit Ratings (ratings) remain stable. The close of this transaction had been delayed following the antitrust suit from the U.S. Department of Justice; however, the U.S. federal judge cleared the way for the transaction to be completed late in September. The close of the transaction was announced on Oct. 3, 2022. The transaction i

      10/4/22 11:34:00 AM ET
      $CHNG
      $UNH
      Managed Health Care
      Health Care
      Medical Specialities
    • District Court Denies Request to Enjoin Acquisition of Change Healthcare Inc. by UnitedHealth Group Incorporated: Change Healthcare Inc: Announces Special Cash Dividend

        Yesterday, the U.S. District Court for the District of Columbia issued an opinion and final appealable order denying the request made by the U.S. Department of Justice and the States of New York and Minnesota for the Court to enjoin UnitedHealth Group Incorporated (NYSE:UNH) ("UnitedHealth Group") from acquiring Change Healthcare Inc. (NASDAQ:CHNG) (the "Company" or "Change Healthcare") pursuant to the proposed merger (the "Merger") between the Company and a wholly owned subsidiary of UnitedHealth Group, which will result in the combination of the Company and Optum Insight, a part of UnitedHealth Group. The opinion and final appealable order also require UnitedHealth Group and the Compan

      9/20/22 5:15:00 PM ET
      $CHNG
      $UNH
      Managed Health Care
      Health Care
      Medical Specialities
    • Change Healthcare Inc. Reports First Quarter Fiscal 2023 Financial Results

      Revenue growth driven by continued momentum in core business and investment in expanded capabilities Total revenue of $884M, including solutions revenue of $831M; solutions revenue growth of 1.8% driven by increased volume and new sales Change Healthcare Inc. (NASDAQ:CHNG) (the "Company" or "Change Healthcare"), a leading healthcare technology company, today reported financial results for the first quarter of fiscal year 2023 ended June 30, 2022. "Our first quarter growth, despite headwinds from lower COVID-related activities and customer attrition related to the extended merger process, demonstrates the underlying momentum in the business," said Neil de Crescenzo, president and chief

      8/3/22 4:15:00 PM ET
      $CHNG
      Managed Health Care
      Health Care

    $CHNG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Change Healthcare downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded Change Healthcare from Overweight to Neutral and set a new price target of $27.75 from $26.00 previously

      9/20/22 7:30:37 AM ET
      $CHNG
      Managed Health Care
      Health Care
    • Change Healthcare downgraded by Citigroup with a new price target

      Citigroup downgraded Change Healthcare from Buy to Neutral and set a new price target of $27.75

      9/20/22 7:30:06 AM ET
      $CHNG
      Managed Health Care
      Health Care
    • Truist initiated coverage on Change Healthcare with a new price target

      Truist initiated coverage of Change Healthcare with a rating of Hold and set a new price target of $27.75

      9/7/22 7:16:06 AM ET
      $CHNG
      Managed Health Care
      Health Care

    $CHNG
    SEC Filings

    See more
    • SEC Form 15-12G filed by Change Healthcare Inc.

      15-12G - Change Healthcare Inc. (0001756497) (Filer)

      10/13/22 4:31:29 PM ET
      $CHNG
      Managed Health Care
      Health Care
    • SEC Form S-8 POS filed by Change Healthcare Inc.

      S-8 POS - Change Healthcare Inc. (0001756497) (Filer)

      10/3/22 4:16:35 PM ET
      $CHNG
      Managed Health Care
      Health Care
    • SEC Form 25-NSE filed by Change Healthcare Inc.

      25-NSE - Change Healthcare Inc. (0001756497) (Subject)

      10/3/22 9:26:21 AM ET
      $CHNG
      Managed Health Care
      Health Care

    $CHNG
    Financials

    Live finance-specific insights

    See more
    • AM Best Comments on Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries Following Completion of Change Healthcare Inc. Acquisition

      AM Best has commented that the Credit Ratings (ratings) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH) and its insurance subsidiaries remain unchanged following its completed acquisition of Change Healthcare Inc. (Change Healthcare) (Nashville, TN) (NASDAQ:CHNG), a leading health care technology company. The outlooks of these Credit Ratings (ratings) remain stable. The close of this transaction had been delayed following the antitrust suit from the U.S. Department of Justice; however, the U.S. federal judge cleared the way for the transaction to be completed late in September. The close of the transaction was announced on Oct. 3, 2022. The transaction i

      10/4/22 11:34:00 AM ET
      $CHNG
      $UNH
      Managed Health Care
      Health Care
      Medical Specialities
    • District Court Denies Request to Enjoin Acquisition of Change Healthcare Inc. by UnitedHealth Group Incorporated: Change Healthcare Inc: Announces Special Cash Dividend

        Yesterday, the U.S. District Court for the District of Columbia issued an opinion and final appealable order denying the request made by the U.S. Department of Justice and the States of New York and Minnesota for the Court to enjoin UnitedHealth Group Incorporated (NYSE:UNH) ("UnitedHealth Group") from acquiring Change Healthcare Inc. (NASDAQ:CHNG) (the "Company" or "Change Healthcare") pursuant to the proposed merger (the "Merger") between the Company and a wholly owned subsidiary of UnitedHealth Group, which will result in the combination of the Company and Optum Insight, a part of UnitedHealth Group. The opinion and final appealable order also require UnitedHealth Group and the Compan

      9/20/22 5:15:00 PM ET
      $CHNG
      $UNH
      Managed Health Care
      Health Care
      Medical Specialities
    • Change Healthcare Inc. Reports First Quarter Fiscal 2023 Financial Results

      Revenue growth driven by continued momentum in core business and investment in expanded capabilities Total revenue of $884M, including solutions revenue of $831M; solutions revenue growth of 1.8% driven by increased volume and new sales Change Healthcare Inc. (NASDAQ:CHNG) (the "Company" or "Change Healthcare"), a leading healthcare technology company, today reported financial results for the first quarter of fiscal year 2023 ended June 30, 2022. "Our first quarter growth, despite headwinds from lower COVID-related activities and customer attrition related to the extended merger process, demonstrates the underlying momentum in the business," said Neil de Crescenzo, president and chief

      8/3/22 4:15:00 PM ET
      $CHNG
      Managed Health Care
      Health Care

    $CHNG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Rareshide Paul was granted 9,177 shares and returned $302,073 worth of shares to the company (49,968 units at $6.05), closing all direct ownership in the company

      4 - Change Healthcare Inc. (0001756497) (Issuer)

      10/5/22 4:32:34 PM ET
      $CHNG
      Managed Health Care
      Health Care
    • SEC Form 4: Domenici Nella returned 29,280 shares to the company, closing all direct ownership in the company

      4 - Change Healthcare Inc. (0001756497) (Issuer)

      10/5/22 4:32:12 PM ET
      $CHNG
      Managed Health Care
      Health Care
    • SEC Form 4: De Crescenzo Neil E. returned $15,274,411 worth of shares to the company (1,557,392 units at $9.81) and was granted 220,264 shares, closing all direct ownership in the company

      4 - Change Healthcare Inc. (0001756497) (Issuer)

      10/5/22 4:31:54 PM ET
      $CHNG
      Managed Health Care
      Health Care

    $CHNG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Change Healthcare Inc. (Amendment)

      SC 13G/A - Change Healthcare Inc. (0001756497) (Subject)

      2/2/23 5:01:01 PM ET
      $CHNG
      Managed Health Care
      Health Care
    • SEC Form SC 13D filed by Change Healthcare Inc.

      SC 13D - Change Healthcare Inc. (0001756497) (Subject)

      10/7/22 3:12:53 PM ET
      $CHNG
      Managed Health Care
      Health Care
    • SEC Form SC 13G/A filed by Change Healthcare Inc. (Amendment)

      SC 13G/A - Change Healthcare Inc. (0001756497) (Subject)

      2/14/22 11:59:59 AM ET
      $CHNG
      Managed Health Care
      Health Care

    $CHNG
    Leadership Updates

    Live Leadership Updates

    See more
    • OptumInsight and Change Healthcare Combine to Advance a More Modern, Information and Technology-Enabled Health Care Platform

      EDEN PRAIRIE, Minn. & NASHVILLE, Tenn.--(BUSINESS WIRE)--Optum, a diversified health services company and part of UnitedHealth Group (NYSE: UNH), and Change Healthcare (NASDAQ: CHNG), a health care technology leader, have agreed to combine. Change Healthcare will join with OptumInsight to provide software and data analytics, technology-enabled services and research, advisory and revenue cycle management offerings to help make health care work better for everyone. This combination unites two technology and service companies focused on serving health care. Their combined capabilities will more effectively connect and simplify core clinical, administrative and payment processes - resu

      1/6/21 6:00:00 AM ET
      $UNH
      $CHNG
      Medical Specialities
      Health Care
      Managed Health Care